13G Filing: Rima Senvest Management and Medigus Ltd. (MDGS)

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Senvest Management 0 5,593,321 0 5,593,321 5,593,321 3.81%
Richard Mashaal 0 5,593,321 0 5,593,321 5,593,321 3.81%

Follow Richard R. Mashaal's Rima Senvest Management

Page 1 of 7 – SEC Filing

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of 1934
(Amendment No. 3)*

Medigus Ltd.

(Name of Issuer)

Ordinary
Shares, par value NIS 0.10 per share

(Title of Class of Securities)

58471G201

(CUSIP Number)

August 21,
2017

(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
(Page 1 of 7 Pages)

______________________________

*The remainder of
this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required
in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act“) or otherwise subject to the liabilities of that section of the Act but shall be subject
to all other provisions of the Act (however, see the Notes).

Follow Medigus Ltd. (NASDAQ:MDGS)

Page 2 of 7 – SEC Filing

1

NAME OF REPORTING PERSON

Senvest Management, LLC

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

5,593,321 (including 8,214 ADSs representing 410,700
Ordinary Shares and including 750,000 Ordinary Shares issuable upon exercise of warrants)

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

5,593,321 (including 8,214 ADSs representing 410,700
Ordinary Shares and including 750,000 Ordinary Shares issuable upon exercise of warrants)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

5,593,321 (including 8,214 ADSs representing 410,700
Ordinary Shares and including 750,000 Ordinary Shares issuable upon exercise of warrants)

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

3.81%

12

TYPE OF REPORTING PERSON

OO, IA

Follow Medigus Ltd. (NASDAQ:MDGS)

Page 3 of 7 – SEC Filing

1

NAME OF REPORTING PERSON

Richard Mashaal

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨

3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Canada

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
5

SOLE VOTING POWER

0

6

SHARED VOTING POWER

5,593,321 (including 8,214 ADSs representing 410,700
Ordinary Shares and including 750,000 Ordinary Shares issuable upon exercise of warrants)

7

SOLE DISPOSITIVE POWER

0

8

SHARED DISPOSITIVE POWER

5,593,321 (including 8,214 ADSs representing 410,700
Ordinary Shares and including 750,000 Ordinary Shares issuable upon exercise of warrants)

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

5,593,321 (including 8,214 ADSs representing 410,700
Ordinary Shares and including 750,000 Ordinary Shares issuable upon exercise of warrants)

10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

3.81%

12

TYPE OF REPORTING PERSON

IN, HC

Follow Medigus Ltd. (NASDAQ:MDGS)

Page 4 of 7 – SEC Filing

Item 1(a). Name of Issuer.
Medigus Ltd. (the “Issuer“)
Item 1(b). Address of Issuer’s Principal Executive Offices.

Omer Industrial Park, No. 7A

P.O. Box 3030

Omer 8496500

Israel

Item 2(a). Name of Person Filing.

This statement is filed by Senvest Management,
LLC and Richard Mashaal.

The reported securities are held in the accounts of Senvest Master
Fund, LP, Senvest Israel Partners Master Fund, LP and Senvest Global (KY), LP (collectively, the “Investment Vehicles“).

Senvest Management, LLC may be deemed to beneficially
own the securities held by the Investment Vehicles by virtue of Senvest Management, LLC’s position as investment manager of each
of the Investment Vehicles. Mr. Mashaal may be deemed to beneficially own the securities held by the Investment Vehicles by virtue
of Mr. Mashaal’s status as the managing member of Senvest Management, LLC. None of the foregoing should be construed in and of
itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.

Item 2(b). Address of Principal Business Office.

Senvest Management, LLC

540 Madison Avenue, 32nd Floor

New York, New York 10022

Richard Mashaal

c/o Senvest Management, LLC

540 Madison Avenue, 32nd Floor

New York, New York 10022

Item 2(c). Place of Organization.

Senvest Management, LLC – Delaware

Richard Mashaal – Canada

Item 2(d). Title of Class of Securities.
Ordinary Shares, par value NIS 0.10 per share
Item 2(e). CUSIP Number.
58471G201

Follow Medigus Ltd. (NASDAQ:MDGS)

Page 5 of 7 – SEC Filing

Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a:
(a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e) ¨ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f) ¨

An employee benefit plan or endowment fund in
accordance with § 240.13d-1(b)(1)(ii)(F);

(g) ¨

A parent holding company or control person in
accordance with §240.13d-1(b)(1)(ii)(G);

(h) ¨

A savings association as defined in Section 3(b)
of the Federal Deposit Insurance Act (12 U.S.C.1813);

(i) ¨

A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
(k) ¨ Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution.
Item 4. Ownership.
The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.  The percentages set forth in this Schedule 13G/A are calculated based upon an aggregate of 146,084,334 Ordinary Shares issued and outstanding as of July 10, 2017, as reported in the Company’s Report of Foreign Private Issuer on Form 6-K filed with the Securities and Exchange Commission on August 16, 2017, and assumes the exercise of the reported warrants.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ý

Follow Medigus Ltd. (NASDAQ:MDGS)

Page 6 of 7 – SEC Filing

Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
The Investment Vehicles have the right to receive and the power to direct the receipt of dividends from, and the proceeds from the sale of, the Ordinary Shares.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow Medigus Ltd. (NASDAQ:MDGS)

Page 7 of 7 – SEC Filing

SIGNATURE

After reasonable inquiry and to the best of
my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and
correct.

Date:  August 22, 2017
SENVEST MANAGEMENT, LLC
By:

/s/ Bobby Trahanas

Name:  Bobby Trahanas
Title:    Chief Compliance Officer
/s/ Richard Mashaal
RICHARD MASHAAL

Follow Medigus Ltd. (NASDAQ:MDGS)